Globeflex Capital’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Globeflex Capital’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-40,200	Closed	-$350K	–	474
2018 Q2	$350K	Sell	40,200 -15,600	-28%	-$140K	0.07%	344
2018 Q1	$566K	Buy	55,800 +35,788	+179%	+$301K	0.12%	264
2017 Q4	$97K	Hold	20,012	–	–	0.03%	359
2017 Q3	$91K	Hold	20,012	–	–	0.03%	342
2017 Q2	$101K	Hold	20,012	–	–	0.02%	352
2017 Q1	$95K	Buy	20,012 +19,900	+17,768%	+$101K	0.02%	405
2016 Q4	$1K	Buy	+112	New	+$615	﹤0.01%	463

Globeflex Capital's JNP Position: Q3 2018 in Review

Globeflex Capital sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 40,200 shares — an estimated $350K sold.

Globeflex Capital first reported a position in JNP in Q4 2016 and held it in 7 quarters. The position peaked at $566K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Globeflex Capital reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Globeflex Capital sold 40,200 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $350K.
Globeflex Capital first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 7 quarters.
Globeflex Capital's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $566K in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Globeflex Capital's 13F filing for Q3 2018, filed 9 Nov 2018.